Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Prostate Cancer

Prostate cancer is one of the most common cancers in men, with more than 40,000 new cases diagnosed every year in the UK. This is usually a slow growing cancer and most men do not notice the symptoms until the cancer has become large enough to press against the urethra and interfere with urination.

What is medical castration?

Differentiating between prostate cancer and prostate enlargement

The International Prostate Symptoms Score (IPSS)

Can Curcumin Prevent or Treat Prostate Cancer?

Symptoms of Benign Prostatic Hyperplasia (BHP)

Prostate Cancer Staging

Palliative treatment and end of life care for prostate cancer

Causes of benign prostatic hyperplasia

Prostate cancer alternative and complementary therapies

Treatment of prostatitis

Prostatitis symptoms

See more featured articles »

Gold Nanoparticles Use in Prostate Cancer

PSA False Positive and False Negative Results

Prostate cancer complications

Prostate Cancer Partin Tables

What is TURP?

Prostate Cancer and Exercise

What is Prostatectomy?

Should MRI be Used to Diagnose Prostate Cancer?

What is Prostatitis?

Prostate Cancer Epidemiology

Breakthroughs in Prostate Cancer Treatments

Cryosurgery for prostate cancer

Types of PSA Test

What is the PCA3 Test?

Causes of prostatitis

Prostate Cancer Cell Dormancy and Activation

Prostate Cancer Questions

Diagnosis of prostatitis

Vasectomy and prostate cancer: Myth or reality?

Radiation therapy for prostate cancer

Hormonal therapy for prostate cancer

Prostate Cancer Symptoms

What is benign prostatic hyperplasia?

Prostate Cancer Epidemiology Worldwide

Gallium Ga 68-labeled PSMA-11 PET/CT Imaging for Prostate Cancer

Prostate Cancer Diagnosis

Treatment of Benign Prostatic Hyperplasia (BHP)

Brachytherapy for Prostate Cancer

Diagnosis of Benign Prostatic Hyperplasia (BPH)

Prostate Biopsy

What is the Gleason Score?

What Should You Avoid Before a PSA Test?

Prostate cancer prevention

Prostate Cancer and Genetics

Survival rates of prostate cancer

Prostate Cancer and Diet

Prostate Cancer Screening

The Prostate

What is the PSA Test?

PSA Test in Men Who Have Been Treated for Prostate Cancer

Prostate Cancer Treatment

Recent Genetic Breakthroughs in Prostate Cancer Research

Choosing the best treatment of prostate cancer - by stage

Life after prostate cancer treatment

Precancerous conditions of the prostate

Single Nucleotide Polymorphisms and Prostate Cancer

Prostate Cancer Risk Factors

Prostate Cancer Research

Rectal Examination for Prostate Cancer

Latest Prostate Cancer News and Research

AI trained on sleep data predicts future disease and mortality years in advance

The SleepFM model reveals how sleep analysis can predict disease risk, offering insights into sleep's role as a vital health indicator for early intervention.

8 Jan 2026

Advanced AI provides accurate guidance for prostate cancer patients

Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large language model to provide accurate, patient-specific prostate cancer education.

7 Jan 2026

Dietary exposure to food preservatives associated with higher cancer incidence

Higher intake of food preservatives, widely used in industrially processed foods and beverages to extend shelf-life, is associated with a modestly increased risk of cancer, finds a study from France published by The BMJ today.

7 Jan 2026

Breakthrough treatment for advanced prostate cancer could eliminate severe side effects

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving therapy.

7 Jan 2026

AI model can predict a person's disease risk using sleep data

A poor night's sleep portends a bleary-eyed next day, but it could also hint at diseases that will strike years down the road.

6 Jan 2026

New trial aims to improve both survival and quality of life for men with advanced prostate cancer

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance A032304) to explore whether doctors can optimize the timing of targeted radiation therapy to minimize side effects while preserving efficacy in men with advanced prostate cancer.

5 Jan 2026

In the vast expanses of Indian country, broadband gaps create health gaps, too

Standing atop Ferry Butte, Frances Goli scanned the more than half a million acres of Shoshone-Bannock tribal land below as she dug her hands into the pockets of a pink pullover.

17 Dec 2025

Early scans reveal prostate radiotherapy toxicity risk

Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of side effects, a study suggests.

11 Dec 2025

Triaptosis could be a promising strategy in the fight against cancer

Cancer remains one of the most critical global public health challenges, exerting profound social, economic, and clinical burdens while limiting gains in human life expectancy.

10 Dec 2025

Generative AI aids discovery of ISM3830's novel scaffold

Casitas B-lineage lymphoma-b (CBLB) is an E3 ubiquitin–protein ligase that functions as an intracellular checkpoint and master negative regulator of T‑cell and natural killer (NK) cell activation, playing a central role in modulating T-cell activation and immune tolerance, and its inhibition enhances T cells and NK cells function, also provides a strategy for the function restoration of exhausted T cells.

1 Dec 2025

Triaptosis-based therapeutic innovations could offer renewed hope for cancer patients

Cancer remains one of the most critical global public health challenges, exerting profound social, economic, and clinical burdens while limiting gains in human life expectancy.

1 Dec 2025

Shorter hormone therapy may be enough for many men with prostate cancer

A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first 9 to 12 months.

25 Nov 2025

Genetic signals reveal why erectile dysfunction develops and who is most at risk

This multi-ancestry genomic study identifies key genetic loci underlying erectile dysfunction and shows that ED risk is shaped by both cardiometabolic and substance use–related genetic pathways. Using EHR-linked data, the researchers uncover SIM1-related mechanisms, modest PRS performance, and bidirectional genetic links with obesity, diabetes, and addiction traits.

25 Nov 2025

Landmark prostate cancer screening trial launches in the UK

The first men have been invited to take part in Prostate Cancer UK's TRANSFORM trial, kicking off the biggest prostate cancer screening study in a generation.

22 Nov 2025

Evidence links severe gum disease to erectile dysfunction and broader men’s health risks

A healthy mouth is also key to a healthy body, as gum disease has been linked to non-communicable diseases such as diabetes, cardiovascular disease, rheumatoid arthritis and Alzheimer's.

20 Nov 2025

Study uncovers promising therapeutic strategies against neuroendocrine prostate cancer

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

20 Nov 2025

Single-port robotic surgery transforms cancer care at NYU Langone Hospital—Long Island

After enduring seven prior abdominal surgeries, 64-year-old Joy Monetti from Islip was no stranger to painful procedures and lengthy recoveries.

17 Nov 2025

Age impacts systemic therapy outcomes in metastatic prostate cancer

Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new study says one more factor should be considered – chronological age.

10 Nov 2025

UCLA team receives grant to establish new clinical cancer research center for veterans

Dr. Matthew Rettig and his research team have been awarded a Clinical Cancer Research Center grant from the U.S. Department of Veterans Affairs to establish a new clinical cancer research center that will expand access to precision oncology clinical trials and patient care for veterans across the Southwest United States.

10 Nov 2025